1. Home
  2. TFIN vs ANIP Comparison

TFIN vs ANIP Comparison

Compare TFIN & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TFIN

Triumph Financial Inc.

HOLD

Current Price

$60.03

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$74.24

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFIN
ANIP
Founded
1981
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
TFIN
ANIP
Price
$60.03
$74.24
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$63.00
$110.00
AVG Volume (30 Days)
186.4K
296.8K
Earning Date
04-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
419.23
EPS
N/A
3.32
Revenue
N/A
$206,547,000.00
Revenue This Year
$7.27
$23.05
Revenue Next Year
$11.31
$14.08
P/E Ratio
$66.31
$22.87
Revenue Growth
N/A
2.47
52 Week Low
$42.90
$56.71
52 Week High
$77.84
$99.50

Technical Indicators

Market Signals
Indicator
TFIN
ANIP
Relative Strength Index (RSI) 55.49 47.35
Support Level $58.43 $72.43
Resistance Level $61.97 $77.47
Average True Range (ATR) 1.99 2.10
MACD 0.65 0.37
Stochastic Oscillator 76.43 50.45

Price Performance

Historical Comparison
TFIN
ANIP

About TFIN Triumph Financial Inc.

Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: